Bleomycin For Injection shortage — US supply status & alternatives

Bleomycin For Injection

—

In supply · Australia

Bleomycin for Injection, USP

In supply · 🇦🇺 Australia · short in🇺🇸 US🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Bleomycin For Injection
Brand names	Bleomycin for Injection, USP

Controlled substance	No

Marketing-authorisation holders	PFIZER CANADA ULC, FRESENIUS KABI CANADA LTD

Registrations on file	2

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 1d ago

Critical

🇨🇦

Canada

Medsafe NZ Full · 29d ago

High

Recalls official enforcement reports

🇨🇦

Bleomycin for Injection USP

Drugs and health products · Dec 2023

Class Idetails ↗

Verified timeline regulator events

🇺🇸 21 Dec 2023

critical reported

🇨🇦 21 Dec 2023

high reported

Sources official regulators

🇺🇸

FDA MedWatch

verified 1d ago

verify ↗

🇳🇿

Medsafe NZ Full

verified 29d ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders2 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
Bleomycin For Injection Usp	—	solution	🇨🇦 CA	PFIZER CANADA ULC	Active
Bleomycin For	—	solution	🇨🇦 CA	FRESENIUS KABI CANADA LTD	Active

Mederti Drug Report

Generated 3 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.